Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Bicalutamide

A non-steroidal antiandrogen that blocks the androgen receptor, approved in 1995 in the United Kingdom and the United States for prostate cancer, often together with treatments that lower testosterone. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?It is a mixture of two mirror-image forms (a racemate), but almost all of its activity comes from just one of them, the (R)-enantiomer: the other is essentially inactive.

BicalutamideGo to the active ingredient →
BicalutamideActive ingredientBicalutamideCat. No. P-B075-001CAS 90357-06-5

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.